In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Regency Centers trades 14.5% below a high-confidence fair value of $86.16, indicating potential undervaluation supported by DCF and EV/EBITDA methods. Financial health scores reveal fair but modest profitability and growth, while Monte Carlo outputs show extreme value volatility with a high downside risk of 30.6%. The wide valuation range suggests elevated uncertainty alongside notable upside potential.